0001493152-16-011838.txt : 20160729 0001493152-16-011838.hdr.sgml : 20160729 20160729154001 ACCESSION NUMBER: 0001493152-16-011838 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160729 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160729 DATE AS OF CHANGE: 20160729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enhance Skin Products Inc CENTRAL INDEX KEY: 0001395400 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 841724410 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52755 FILM NUMBER: 161793960 BUSINESS ADDRESS: STREET 1: 695 SOUTH COLORADO BOULEVARD STREET 2: SUITE 480 CITY: DENVER STATE: CO ZIP: 80246 BUSINESS PHONE: (416) 644-8318 MAIL ADDRESS: STREET 1: 695 SOUTH COLORADO BOULEVARD STREET 2: SUITE 480 CITY: DENVER STATE: CO ZIP: 80246 FORMER COMPANY: FORMER CONFORMED NAME: ZEEZOO SOFTWARE CORP. DATE OF NAME CHANGE: 20070404 8-K 1 form8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 29, 2016

Enhance Skin Products Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada

000-52755

84-1724410

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

50 West Liberty Street, Suite 880, Reno NV		80246
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (416) 306—2493

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SECTION 1 - REGISTRANT’S BUSINESS AND OPERATIONS

ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On July 29, 2016, the Company and Biosurface Limited (“Biosurface”) entered into an agreement amending the Option Agreement entered into by the parties on July 7, 2016 (the “Option Amendment Agreement”). The Option Amendment Agreement extends the expiration date of the option in the Option Agreement from July 31, 2016 to August 12, 2016. All other terms of the Option Agreement remain unchanged.

The foregoing description of Option Amendment Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the foregoing document, which is filed as Exhibits 10.1 hereto, and which is incorporated herein by this reference.

SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

10.1	Option Amendment Agreement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Enhance Skin Products Inc.

	By:	/s/ Donald Nicholson
		Donald Nicholson
		President/CEO, Principal Executive Officer

Dated: July 29, 2016

EX-10.1 2 ex10-1.htm

SIDE LETTER

BIOSURFACE LIMITED

Sand Hutton Applied Innovation Campus

Sand Hutton

York

North Yorkshire

YO41 1LZ

England

ENHANCE SKIN PRODUCTS INC.

50 West Liberty Street

Suite 880

Reno

NV 89501

United States of America

July 28, 2016

Re Enhance Skin Products Inc. (the “Company”)

Dear Sirs

We refer to the option agreement, dated 7 July 2016, between (1) BioSurface Limited (“BioSurface”) and (2) the Company (the “Option Agreement”). This letter constitutes a side letter to the Option Agreement.

Save as otherwise provided for in this letter, defined terms used in this letter shall have the meaning ascribed to such terms in the Option Agreement.

We the undersigned being all of the parties to the Option Agreement hereby agree and confirm that, in consideration for the participation by each party hereto in the good faith negotiations in relation to the entry into an asset purchase agreement in relation to certain assets owned by the Company, the Option Agreement shall be amended, in accordance with Clause 10.3 of the Option Agreement, by the deletion of the current Clause 3.2 of the Option Agreement and its replacement with the following new Clause 3.2:

“3.2 The Option shall lapse on 12 August 2016.”

This letter may be executed in any number of counterparts each of which when executed and delivered shall be an original, but all the counterparts together shall constitute one and the same instrument.

This letter shall be governed by the laws of England and Wales and the parties hereby irrevocably submit to the jurisdiction of the courts of England and Wales in relation to any dispute arising from, or in connection with, this letter.

Yours faithfully

Duly authorised, for and on behalf of

BIOSURFACE LIMITED

Duly authorised, for and on behalf of

ENHANCE SKIN PRODUCTS INC.